ATRX and central nervous system cancer: Although no single molecular marker was associated with tumor grade, we find that tumor grade is correlated with the overall mutational load: grade II gliomas harbour fewer genetic changes than grade III or IV, even within defined molecular subtypes (e.g. ATRX mutated gliomas).